Back to Endocrinology
EndocrinologyvStandard_2024Evidence-Based

Glucose Infusion Rate (GIR)

Calculates the rate at which glucose is administered intravenously, particularly important in neonatal and pediatric care to maintain appropriate blood glucose levels. Used to monitor and adjust dextrose infusions to prevent hypoglycemia while avoiding excessive glucose administration.

Clinical Input Parameters

mL/hr
Range: 0.1 — 1000 mL/hr
%
Range: 1 — 50 %
kg
Range: 0.5 — 200 kg
Clinical Assessment
Awaiting Parameters
glucose infusion rate
—mg/kg/min
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Glucose Infusion Rate (GIR) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within endocrinology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

GIR (mg/kg/min) = [Infusion rate (mL/hr) × Dextrose concentration (%) × 10] / [Weight (kg) × 60]. Simplified: GIR = (D × DIR) / 6, where D = dextrose %, DIR = infusion rate in mL/kg/hr

Clinical Pearls & Practice Notes

  • Standard formula: GIR = [Rate × Concentration × 1000] / [Weight × 60 × 100]
  • Simplified mental calculation: GIR = (Dextrose% × mL/kg/hr) / 6
  • Normal baseline glucose utilization in term infants: 4-6 mg/kg/min
  • Preterm infants typically need 5-8 mg/kg/min initially
  • GIR should not fall below 4 mg/kg/min in non-feeding infants
  • Target GIR for optimal nutrition in neonates: 14 mg/kg/min
  • GIR >10-12 mg/kg/min may require Level 3 NICU care
  • GIR >18-20 mg/kg/min increases risk of lipogenesis and liver complications
  • Monitor blood glucose every 4-6 hours when adjusting GIR
  • Common dextrose concentrations: D5W (5%), D10W (10%), D12.5W (12.5%)
  • Central line access often required for dextrose concentrations >12.5%
  • Used extensively in parenteral nutrition protocols
  • Important for preventing neonatal hypoglycemia
  • Consider insulin therapy when GIR >12-15 mg/kg/min with persistent hyperglycemia
  • Gradual GIR reduction recommended when transitioning to enteral feeding

Evidence & Literature Citations

  1. Kalhan SC, Parimi PS. Gluconeogenesis in the fetus and neonate. Semin Perinatol. 2000;24(2):94-106. doi: 10.1053/sp.2000.6360.
  2. Ditzenberger GR, Collins SD, Binder N. Continuous insulin infusion in the management of hyperglycemia in the pediatric intensive care unit. Pediatr Crit Care Med. 2004;5(1):27-32. doi: 10.1097/01.PCC.0000102223.83245.02.
  3. Sinclair JC, Bottino M, Cowett RM. Interventions for prevention of neonatal hyperglycemia in very low birth weight infants. Cochrane Database Syst Rev. 2011;(10):CD007615. doi: 10.1002/14651858.CD007615.pub3.
  4. Hay WW Jr, Raju TN, Higgins RD, Kalhan SC, Devaskar SU. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr. 2009;155(5):612-617. doi: 10.1016/j.jpeds.2009.06.044.

Score Interpretation Ranges

Below Normal Range0 – 3.9 pts

Insufficient glucose delivery

Normal/Physiologic Range4 – 8 pts

Appropriate glucose delivery

Moderate/Therapeutic Range8.1 – 12 pts

Enhanced glucose delivery

High Therapeutic Range12.1 – 18 pts

High glucose delivery for nutrition

Excessive Range18.1 – 50 pts

Risk of metabolic complications

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.